FDA Approves New Indication for Avapritinib
Avapritinib (AYVAKIT) is now approved to treat adults with indolent systemic mastocytosis.
Medscape Medical News
source https://www.medscape.com/viewarticle/992323?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992323?src=rss
Comments
Post a Comment